Court Orders North Carolina Pharmacy to Pay $500,000 Penalty and Enters Injunction to Prevent Filling Illegal Controlled Substance Prescriptions
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Court Orders North Carolina Pharmacy to Pay $500,000 Penalty and Enters Injunction to Prevent Filling Illegal Controlled Substance Prescriptions

Court Orders North Carolina Pharmacy to Pay $500,000 Penalty and Enters Injunction to Prevent Filling Illegal Controlled Substance Prescriptions

Diciembre 06, 2024
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

diversion control emblem on green background

WASHINGTON – A federal court ordered an Elkin, North Carolina, pharmacy to pay a $500,000 penalty and enjoined the pharmacy and its pharmacists from dispensing controlled substances, including opioids, without taking steps to help ensure the drugs will not be abused or diverted.

The consent decree resolves a complaint filed by the United States on Nov. 27, which alleged that Elk Pharmacy Inc., Larry Irwin, the pharmacy’s owner and pharmacists Susan Baker, S. Jason Couch, Beth Pence and Lori Wyble filled prescriptions in violation of the Controlled Substances Act (CSA). The complaint alleges that the defendants dispensed prescription opioids while disregarding numerous “red flags” — that is, obvious indications of drug abuse, drug diversion and drug-seeking behavior. For example, according to the complaint, the defendants filled dangerous combination prescriptions; filled prescriptions for long-term, high-dose opioids that exceeded known recommendations for treating pain; filled prescriptions for patients who appeared to be “shopping” for doctors or pharmacies; and filled prescriptions written by prescribers known to be suspected of illegal prescribing, including one doctor who the North Carolina Medical Board had barred from prescribing controlled substances.

“The pharmacists at Elk Pharmacy Inc. had a corresponding responsibility, along with the prescribing practitioners, to only dispense prescriptions for a legitimate medical purpose,” said Special Agent in Charge Robert J. Murphy of the DEA Atlanta Division. “The DEA will continue to pursue healthcare providers who are not in compliance with mandatory regulations.”

“Pharmacists have a duty to help protect consumers from the life-threatening dangers of controlled substance abuse,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the Justice Department’s Civil Division. “The department will continue to work with its law enforcement partners to hold medical professionals accountable when they fail to fulfill that duty.”

“Pharmacists are trained professionals who cannot simply rubber-stamp doctors’ prescriptions,” said U.S. Attorney Sandra J. Hairston for the Middle District of North Carolina. “They have an independent responsibility to ensure that the prescriptions they fill are for a legitimate medical purpose.”

The defendants agreed to settle the suit and be bound by a consent decree of permanent injunction. The injunction entered by U.S. District Judge Thomas D. Schroeder for the Middle District of North Carolina prohibits the defendants from filling certain “red flag” prescriptions and requires the defendants to fill other orders only after receiving documentation justifying the prescriptions.

The government was represented by Senior Litigation Counsel Donald R. Lorenzen of the Civil Division’s Consumer Protection Branch and Assistant U.S. Attorney Cassie Crawford for the Middle District of North Carolina, with substantial assistance from the DEA Greensboro Resident Office’s Diversion Group.

For more information about the enforcement efforts of the Consumer Protection Branch visit www.justice.gov/civil/consumer-protection-branch.

                                        

                                                             ###

Download Press Release
###
Opioids
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Robert Murphy Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster